TRAIL (Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand) mediated Apoptosis of human breast cancer cells sensitized by dietary flavonoid Kaempferol

Yogesh Pandey¹ , Syed Hassan Mehdi² , Md. Asad Khan³ , Preeti Bhatt⁴ , Chandra Kala Pant⁵

Section:Research Paper, Product Type: Isroset-Journal
Vol.5 , Issue.6 , pp.8-14, Dec-2018

CrossRef-DOI:   https://doi.org/10.26438/ijsrbs/v5i6.814

Online published on Jan 01, 2018

Copyright © Yogesh Pandey, Syed Hassan Mehdi, Md. Asad Khan, Preeti Bhatt, Chandra Kala Pant . This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 

View this paper at   Google Scholar | DPI Digital Library

XML View     PDF Download

How to Cite this Paper

491 Views    263 Downloads    96 Downloads

Abstract :
Kaempferol is one of the most prevailing flavonoid distributed in edible plants while TRAIL(tumor necrosis factor-related apoptosis-inducing ligand)is a promising anti-cancer agent. Resistance to TRAIL, limits its potential as a drug for cancer therapy. Cytotoxicity induced by Kaempferol and TRAIL alone and in combination was measured by MTT assay. Apoptosis was detected by DNA fragmentation assay and measured by real time PCR and western blotting techniques. The study clearly showed the dose dependent cytotoxic effect of Kaempferol in combination with TRAIL in all the breast cancer cells. The dying cells showed characteristics of apoptosis such as DNA fragmentation in combined treatment with Kaempferol and TRAIL in human breast cancer cells appreciably, compared to single treatments. Furthermore, it has also been found that treatment with Kaempferol enhances TRAIL-induced apoptosis by increasing expression of apoptosis-related proteins including caspase-3, 8, 9 and Bax and by decreasing the expression of Bcl-2. The present work for the first time shows that the combined treatment with Kaempferol and TRAIL drastically induced apoptosis in human breast cancer cells as compared to single treatment. Thus, the data clearly demonstrates that Kaempferol sensitizes human breast cancer cells to TRAIL-mediated apoptosis, which could have potential therapeutic significance in treating breast cancer.

Key-Words / Index Term :
Apoptosis, Kaempferol; TRAIL; Breast cancer;Cytotoxicity

References :
[1]. I.Hedberg, “Botanical methods in ethnopharmacology and the need for conservation of medicinal plants” Journal of Ethnopharmacology, Vol.38, pp.121–28,1993.
[2]. M. Heinrich, S. Gibbons “Ethnopharmacology in drug discovery: an analysis of its role and potential contribution” Journal of Pharmacy and Pharmacology, Vol.53, pp. 425–32, 2001
[3]. N. Katsube, K.Iwashita, T. Tsushida, K. Yamaki, M. Kobori, “Induction of apoptosis in cancer cells by Bilberry (Vacciniummyrtillus) and the anthocyanins” Journal of Agricultural and Food Chemistry, Vol.51, pp. 68-75, 2003.
[4]. MA. Richardson, “Biopharmacologic and herbal therapies for cancer: research update from NCCAM” Journal of Nutrition, Vol. 131, pp. 3037-40, 2001
[5]. M.J. Wargovich, C. Woods, D.D.Hollis, M.E.Zander , “Herbals, cancer prevention and health” Journal of Nutrition Vol. 131, pp. 3034-36, 2001.
[6]. K.A.Abo, A.A. Adeyemi, D.A. Adeite, “Ethnobotanical survey of plants used in the treatment of infertility and sexually transmitted diseases in southwest Nigeria” African Journal of Medical Sciences, Vol. 29, pp.325–27, 2000
[7]. A. Ankli et al, “Yucatec Mayan medicinal plants: evaluation based on indigenous uses” Journal of Ethnopharmacology Vol. 79, pp. 43–52. 2002
[8]. G. Pinn, “Herbs used in obstetrics and gynaecology” Australian Family Physician Vol. 30,pp. 351-56, 2001
[9]. Y.J. Surh, “Cancer chemoprevention with dietary phytochemicals” Nature Review Cancer Vol.3,pp.768–80, 2003
[10]. C.S.Yang et al, “Inhibition of carcinogenesis by dietary polyphenolic compounds” Annual Review of Nutrition, Vol.21,pp. 381–06, 2001
[11]. K. Bimlesh el a., “A Review of Phytochemistry and Pharmacology of Flavonoids” International Journal of Pharmaceutical Sciences, Vol.1,pp. 25-41, 2011
[12]. D. Agarwal, “Pharmacological Activities of flavonoids” International Journal of Pharmaceutical Sciences and Nanotechnology, Vol. 4, pp. 1394-98, 2011.
[13]. H.W. Leung el a., “Kaempferol induces apoptosis in human lung non-small carcinoma cells accompanied by an induction of antioxidant enzymes” Food and Chemical Toxicology,Vol. 45,pp. 13, 2007.
[14]. V. Sharma el al, “Kaempferol induces apoptosis in glioblastoma cells through oxidative stress” Molecular Cancer Therapeutics, Vol.6, pp.2544–53, 2007.
[15]. T.T.Nguyen et al, “Kaempferol-induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK-MAPK” Journal of Cellular Physiology, Vol. 197, pp. 110-121, 2003.
[16]. Q. Zhou et al, “Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin” Molecular Cancer Therapeutics, Vol.8, pp. 1684-91, 2009.
[17]. J.P. Sheridan et al, “Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors” Science, Vol. 277, pp.818–21, 1997.
[18]. H.Walczak et al, “TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL” EMBO Journal, Vol.16, pp. 5386–97, 1997.
[19]. H. Walczak et al, “Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in viv” Nature Medicine, Vol. 5, pp.157–63, 1999.
[20]. D. Lawrence et al, “Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions” Nature Medicine, Vol.7, pp. 383–85, 2001.
[21]. L. Zhang, B. Fang, “Mechanisms of resistance to TRAIL-induced apoptosis in cancer” Cancer Gene Therapy, Vol.12, pp. 228–37, 2005.
[22]. S.H. Mehdi, A. Qamar, “Paraquat-induced ultrastructural changes and DNA damage in the nervous system is mediated via oxidative-stress induced cytotoxicity in Drosophila melanogaster” Toxicological Sciences, Vol.134 (2), pp. 355-365, 2013.
[23]. S.H. Mehdi, A. Qamar, Md. Zafaryab, S. Nafees, M.A. Rizvi, “ Malathion induced cell injury and cell death in the nervous system via oxidative stress induced cytotoxicity in Drosophila melanogaster” International Journal of Scientific Research, Vol. 6 (12), pp. 447-450, 2018.
[24]. J. Sambrook, D.W. Russell, “Molecular Cloning: A Laboratory Manual” Cold Spring Harbor Laboratory Press, Vol.3rd , 2001.
[25]. M.K. Manion, D.M. Hockenbery, “Targeting BCL-2-related proteins in cancer therapy” Cancer Biology and Therapeutics, Vol. 2, pp.105–14, 2003.
[26]. H.N. LeBlanc, A. Ashkenazi, “Apo2L/TRAIL and its death and decoy receptors” Cell Death and Differentiation, Vol. 10, pp.66–75, 2003.
[27]. Y. Zhang, B. Zhang, “TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5” Molecular Cancer Research. Vol. 6(12), pp.1861-71, 2008.
[28]. C. Clemedson, B. Ekwall,”Overview of the final MEIC results: The in vitro–in vitro evaluation” Toxicology In Vitro, Vol. 13, pp.657–63, 1999.
[29]. M.E. Scheers, B.A. Ekwall, J.P. Dierickx, “In vitro long-term cytotoxicity testing of 27 MEIC chemicals on HepG2 cells and comparison with acute human toxicity data” Toxicology In Vitro Vol.15, pp. 153–61, 2001.